But then there were still a third group of labs that had persistent problems with both N1 and N3. For these labs, the interim solution wouldn’t work, because the tests would be generating inconclusive results. They had to wait for the remanufactured kits to arrive, and in the meantime send their samples to the CDC and see if the agency would agree to test them. The public health labs in New York City and New York State were in this third group, and they were effectively out of the testing business until the CDC was able to replace its faulty kits with ones that worked.
